Lilly Closes Dermira’s Menlo Park Facility
Eli Lilly is cutting 163 jobs by closing its Dermira facility in Menlo Park, Calif. and selling off the latter company’s sweat drug Qbrexza, which is being acquired by Journey Medical.
New Search
If you are not happy with the results below please do another search
Search
50 search results for:
U.S. Justice Department backs extending ban on fentanyl copycats
/in Congress, Copycats, Drug Enforcement Agency (DEA), Fentanyl, Opioid Epidemic, Opioids, U.S. Justice Department, United StatesThe U.S. Justice Department signaled support for legislation to extend by seven months a ban on illegal copycat versions of fentanyl, the powerful synthetic painkiller that has helped fuel the nation’s opioid epidemic.
J&J Covid-19 vaccine delay will not impact U.S. vaccination plan: White House
/in Business, COVID-19 Vaccinations, COVID-19 Vaccines, FDA, Janssen COVID-19 Vaccine (J&J), Johnson & Johnson, Moderna, Pfizer, U.S. Centers for Disease Control and Prevention, White HouseThe pause of Johnson & Johnson’s Covid-19 vaccine will not slow U.S. vaccination efforts, the White House COVID-19 coordinator said on April 13, adding that officials were working to reschedule people with other shots made by Pfizer and Moderna.
MAHF Moves Awards Dinner to 2022 to Ensure Safety
/in Business, Healthcare Communications Agencies, Healthcare Communications Networks, Marketing & Advertising, Medical Advertising Hall Of Fame (MAHF), People on the MoveThe Medical Advertising Hall of Fame announced on April 13 the postponement of its annual dinner to ensure the safety of the MAHF’s constituents. The 2021 inductees – Risa Bernstein, Maris Schilling, and Ronal Souza – will be honored at the 2022 dinner.
FDA Approves Self-Injectable Form of Xolair
/in Allergic Asthma, Blockbusters, Chronic Idiopathic Urticaria, FDA, Genentech, Nasal Polyps, Novartis, Roche, Self-injections, Supplemental Biologics License Application (sBLA), TherapeuticsThe U.S. Food and Drug Administration approved a prefilled syringe for self-injection of the allergic diseases treatment Xolair developed by Novartis and Genentech, a Roche company.
U.S. pauses J&J Covid-19 vaccine over rare blood clots
/in AstraZeneca, Blood Clots, Coronavirus Disease (COVID-19) Pandemic, COVID-19 Vaccines, Deaths, Europe, FDA, Janssen, Janssen COVID-19 Vaccine (J&J), Johnson & Johnson, U.S. Centers for Disease Control and PreventionU.S. federal health agencies on April 13 recommended pausing the use of Johnson & Johnson’s Covid-19 vaccine after six women under 50 given the shot developed rare blood clots, dealing a fresh setback to efforts to tackle the pandemic.
U.S. COVID cases march higher, hospitalizations up for second week in a row
/in COVID-19 cases, United StatesThe United States reported an 8 percent rise in new cases of Covid-19 to 490,000 during the week ended April 11, the fourth week in a row that infections have increased, according to a Reuters analysis of state and county data.
SAATCHI & SAATCHI WELLNESS STRENGTHENS EXECUTIVE LEADERSHIP TEAM
/in Appointments, Healthcare Communications Agencies, Healthcare Communications Networks, Marketing & Advertising, New Hire, People on the MoveSaatchi & Saatchi Wellness (SSW)—a leading integrated global health and wellness agency and a Publicis Health company—expanded its executive leadership team with the addition of three key appointments: Margot Grover was named Head of Strategy; Jill Cusick was appointed SVP, Human Resources; and Chris Harris was hired as Managing Director.
Movement Disorder Therapy Reduces Tremor Score in Study
/in Biogen, Clinical Trials, Essential Tremor, Movement Disorders, R&D, ResearchersTopline results from a Phase II study show SAGE-324, Sage Therapeutics’ investigational oral neuroactive steroid GABAA receptor positive allosteric modulator, significantly reduced tremor score in adult patients with essential tremor.
More therapeutics but no surge in vaccine for Michigan, Biden administration says
/in COVID-19 cases, COVID-19 Vaccines, Janssen COVID-19 Vaccine (J&J), Joe Biden, Johnson & Johnson, Michigan, U.S. Centers for Disease Control and Prevention, U.S. government, White HouseThe White House said on April 12 that it was prepared to send additional therapeutic treatments to the state of Michigan, which is experiencing a worrying number of Covid-19 cases, but declined to promise more vaccine as the state has sought.
